Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levofloxacin versus ciprofloxacin for community-acquired bacterial urinary tract infection in adults with chronic kidney disease
PACTR202401622249032Phase 3Completed
- Sponsor
- Dhikrullah Adebayo
- Start
- Oct 2022
- Modality
- Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of levofloxacin and ciprofloxacin in urinary tract infection (UTI) (2 arms), sponsored by Dhikrullah Adebayo. Primary endpoints: Clinical efficacy and Drug tolerability. Started Oct 2022; status: completed.
02
Drugs
levofloxacinciprofloxacin
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on PACTR202401622249032.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202401622249032.